While brain health conditions are increasing worldwide, development of safe and effective interventions are lagging behind. Development and testing of interventions in brain health conditions typically rely on classical clinical study designs where participants are assessed using clinical scales that are administered at infrequent visits to a clinic.
Digital technologies hold the promise to improve the quality of life for patients living with brain disease as well as the development of new therapies. For example:
• remote assessments enable frequent and versatile assessment of a patient’s symptoms and health status in a real-world setting which can lower the burden of in-clinic testing, increase patient recruitment, and reduce the effects of day-to-day variation that can otherwise compromise clinical study results
• passive monitoring enable high-frequency assessment with a minimal burden to patients through novel modalities, capturing new streams of data about patients, and can also be used to track the safety of individuals at risk of adverse outcomes, which may enable a greater degree of independence
• digital interventions enable delivery of health services directly to the patient, in a cost-effective way, reaching more patients than traditional healthcare services, and can also enable more personalized delivery of digital and/or pharmacological medicine
This Research Topic welcomes all papers related to digital assessment and monitoring of brain health and digital intervention in brain health conditions. Relevant topics include, but are not limited to:
• Cognitive testing
• Mental wellbeing
• Wearable sensors for passive tracking
• Non-intrusive systems (Internet of Things setups) for passive data collection
• Digital interventions for prevention or treatment (digital therapeutics)
• Combination of digital and pharmacological interventions
---
Dr. Lars Lau Raket is an employee of Novo Nordisk A/S. All other Topic Editors declare no conflicts of interest.
While brain health conditions are increasing worldwide, development of safe and effective interventions are lagging behind. Development and testing of interventions in brain health conditions typically rely on classical clinical study designs where participants are assessed using clinical scales that are administered at infrequent visits to a clinic.
Digital technologies hold the promise to improve the quality of life for patients living with brain disease as well as the development of new therapies. For example:
• remote assessments enable frequent and versatile assessment of a patient’s symptoms and health status in a real-world setting which can lower the burden of in-clinic testing, increase patient recruitment, and reduce the effects of day-to-day variation that can otherwise compromise clinical study results
• passive monitoring enable high-frequency assessment with a minimal burden to patients through novel modalities, capturing new streams of data about patients, and can also be used to track the safety of individuals at risk of adverse outcomes, which may enable a greater degree of independence
• digital interventions enable delivery of health services directly to the patient, in a cost-effective way, reaching more patients than traditional healthcare services, and can also enable more personalized delivery of digital and/or pharmacological medicine
This Research Topic welcomes all papers related to digital assessment and monitoring of brain health and digital intervention in brain health conditions. Relevant topics include, but are not limited to:
• Cognitive testing
• Mental wellbeing
• Wearable sensors for passive tracking
• Non-intrusive systems (Internet of Things setups) for passive data collection
• Digital interventions for prevention or treatment (digital therapeutics)
• Combination of digital and pharmacological interventions
---
Dr. Lars Lau Raket is an employee of Novo Nordisk A/S. All other Topic Editors declare no conflicts of interest.
